Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	52,125	46,208	46,128	80,883	56,859	48,657
Market Cap Growth	14.12%	0.17%	-42.97%	42.25%	16.86%	51.96%
Enterprise Value	51,127	45,258	45,604	80,106	56,151	47,819
PE Ratio	37.28	32.95	30.31	53.81	69.05	46.48
PS Ratio	8.48	7.70	8.57	15.46	12.96	11.19
PB Ratio	7.32	6.95	7.94	13.86	12.43	11.73
P/FCF Ratio	192.06	71.88	47.38	57.51	87.84	52.40
P/OCF Ratio	98.68	51.58	37.87	46.70	53.93	41.13
EV/Sales Ratio	8.32	7.54	8.47	15.31	12.80	11.00
EV/EBITDA Ratio	28.28	25.26	23.35	42.53	52.58	36.73
EV/EBIT Ratio	31.36	27.96	25.53	46.56	60.22	40.28
EV/FCF Ratio	188.38	70.41	46.84	56.96	86.75	51.50
Debt / Equity Ratio	0.10	0.10	0.12	0.12	0.15	0.16
Debt / EBITDA Ratio	0.39	0.39	0.35	0.37	0.65	0.52
Debt / FCF Ratio	2.58	1.08	0.71	0.49	1.07	0.73
Quick Ratio	2.32	2.08	1.87	2.07	2.24	2.34
Current Ratio	3.76	3.38	3.03	3.08	3.46	3.31
Asset Turnover	0.66	0.66	0.64	0.66	0.66	0.74
Interest Coverage	92.64	91.97	93.05	93.50	59.02	57.35
Return on Equity (ROE)	21.10%	21.90%	25.60%	28.40%	19.90%	28.10%
Return on Assets (ROA)	15.10%	15.40%	18.00%	19.10%	12.40%	17.80%
Return on Capital (ROIC)	16.89%	17.98%	22.70%	21.19%	15.53%	21.32%
Earnings Yield	2.71%	3.04%	3.30%	1.86%	1.45%	2.15%
FCF Yield	0.52%	1.39%	2.11%	1.74%	1.14%	1.91%
Buyback Yield / Dilution	1.11%	2.37%	1.11%	0.11%	0.75%	0.66%
Total Shareholder Return	1.11%	2.37%	1.11%	0.11%	0.75%	0.66%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).